Literature DB >> 1280615

Intermediate filament expression in mesotheliomas: leiomyoid mesotheliomas are not uncommon.

F G Mayall1, H Goddard, A R Gibbs.   

Abstract

In this study we examined intermediate filament expression in 45 formalin-fixed mesotheliomas. Immunostaining for cytokeratin was found in 86%, for vimentin in 71%, and for desmin in 4%; none stained for glial fibrillary acidic protein or neurofilament. The two biphasic mesotheliomas which expressed desmin also expressed smooth muscle actin but were negative for myoglobin. This, together with the ultrastructural findings, was taken as unequivocal evidence of a leiomyoid form of mesothelioma which might easily be confused with leiomyosarcoma. Both of these tumours co-expressed cytokeratin, exemplifying the value of cytokeratin immunostaining in the distinction between mesothelioma and sarcoma. Consistent non-expression of glial fibrillary acidic protein in mesotheliomas may help to distinguish them from nerve sheath tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280615     DOI: 10.1111/j.1365-2559.1992.tb00430.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  My approach to the diagnosis of mesothelial lesions.

Authors:  K J Butnor
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

2.  Serosal reaction in chronic gastric ulcers: an immunohistochemical and ultrastructural study.

Authors:  M A Pitt; N Y Haboubi
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

3.  Diagnosis and prognosis of malignant mesothelioma of the tunica vaginalis testis.

Authors:  Bo Hai; Yu Yang; Yajun Xiao; Bing Li; Chaohui Chen
Journal:  Can Urol Assoc J       Date:  2011-09-08       Impact factor: 1.862

4.  Thoracic mesenchymal malignant tumors and programed cell death ligand-1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas.

Authors:  Kanji Otsubo; Hiroki Sakai; Hiroyuki Kimura; Tomoyuki Miyazawa; Hideki Marushima; Koji Kojima; Naoki Furuya; Masamichi Mineshita; Motohiro Chosokabe; Junki Koike; Hisashi Saji
Journal:  Thorac Cancer       Date:  2021-10-15       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.